VivoSeq
Other

Neonatal Infection

0

Pipeline Programs↗

2

Active Trials↗

0

Companies Involved↗

Neonatal Infection is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

10/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

5

clinical trials

Completed3 · 60%
Not yet recruiting2 · 40%

Clinical Trials

Trial Activity

Azithromycin for Preventing Maternal and Neonatal Infections During Labor.
Not yet recruiting·—·Phase 4·NCT06958146·400 enrolled
Intravenous Immune Globulin (IVIG) to Prevent Neonatal Infection
Completed·NNICHD Neonatal Research Network·Phase 2/3·NCT01203345·2,416 enrolled
Integrative Approach to Identify Environmental Risk Factors for CC-17 Group B Streptococcal Neonatal Infection
Completed·AAssistance Publique - Hôpitaux de Paris·N/A·NCT02471937·151 enrolled
Etiology, Prevention and Treatment of Neonatal Infections in the Community
Completed·JJohns Hopkins Bloomberg School of Public Health·N/A·NCT00198627·16,359 enrolled
Against Chikungunya Virus and Neonatal Infection
Not yet recruiting·—·N/A·NCT07190560·60 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)